Literature DB >> 6246161

Effect of short dexamethasone suppression on plasma steroids in prepubertal and pubertal girls.

C Pintor, F Facchinetti, R Puggioni, A Faedda, C Massafra, R Corda, A R Genazzani.   

Abstract

In 40 girls aged from 2 to 14 years, subdivided into groups according to age and pubertal development, and in 6 adult female volunteers, plasma cortisol (F), pregnenolone (delta 5), dehydroepiandrosterone (DHA) progesterone (P), 17-hydroxyprogesterone (17P), androstenedione (A), testosterone (T) and estradiol (E2) were measured before and after short dexamethasone (DXM) suppression. The results confirmed the capacity of DXM to inhibit plasma steroids in all age groups, except T in 2-9 year old and P1 Tanner's stage girls. The percentage suppression of each given steroid was constant over the age groups from 6-9 years to P4-5 Tanner's stage, while lower suppression was found in 17P, P and DHA in 2-5 year old girls and in 17P, DHA and E2 in adult women. These results emphasize the fundamental role of ACTH as the overall stimulating factor of adrenal steroidogenesis but do not negate the possibility of another factor responsible for the development of the adrenal androgen secreting cells throughout prepuberty and puberty.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6246161     DOI: 10.1007/BF03348213

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  20 in total

1.  Levels of luteinizing hormone, follicle-stimulating hormone, testosterone and dihydrotestosterone in the circulation of sexually maturing intact male rats and after orchidectomy and experimental bilateral cryptorchidism.

Authors:  D Gupta; K Rager; J Zarzycki; M Eichner
Journal:  J Endocrinol       Date:  1975-08       Impact factor: 4.286

2.  Changes in plasma 11-hydroxycorticosteroids after ACTH, insulin and dexamethasone in neonatal infants.

Authors:  A Okuno; Y Nishimura; T Kawarazaki
Journal:  J Clin Endocrinol Metab       Date:  1972-03       Impact factor: 5.958

3.  Ovarian and adrenal contribution to peripheral androgens during the menstrual cycle.

Authors:  G E Abraham
Journal:  J Clin Endocrinol Metab       Date:  1974-08       Impact factor: 5.958

4.  Critical assessment of celite column chromatography in a multiple steroid radioimmunoassay system.

Authors:  F Facchinetti; A R Genazzani
Journal:  J Nucl Med Allied Sci       Date:  1978 Apr-Jun

5.  Adrenal and gonadal steroids in girls during sexual maturation.

Authors:  A R Genazzani; C Pintor; F Facchinetti; G Carboni; U Pelosi; R Corda
Journal:  Clin Endocrinol (Oxf)       Date:  1978-01       Impact factor: 3.478

6.  Androstenedione production and interconversion rates measured in peripheral blood and studies on the possible site of its conversion to testosterone.

Authors:  R Horton; J F Tait
Journal:  J Clin Invest       Date:  1966-03       Impact factor: 14.808

7.  Hormonal changes in puberty. IV. Plasma estradiol, LH, and FSH in prepubertal children, pubertal females, and in precocious puberty, premature thelarche, hypogonadism, and in a child with a feminizing ovarian tumor.

Authors:  M R Jenner; R P Kelch; S L Kaplan; M M Grümbach
Journal:  J Clin Endocrinol Metab       Date:  1972-03       Impact factor: 5.958

8.  Unconjugated dehydroepiandrosterone plasma levels in normal subjects from birth to adolescence in human: the use of a sensitive radioimmunoassay.

Authors:  E de Peretti; M G Forest
Journal:  J Clin Endocrinol Metab       Date:  1976-11       Impact factor: 5.958

9.  Dehydroepiandrosterone sulfate (DS) levels, a rapid test for abnormal adrenal androgen secretion.

Authors:  S Korth-Schutz; L S Levine; M I New
Journal:  J Clin Endocrinol Metab       Date:  1976-06       Impact factor: 5.958

10.  Puberty in girls: correlation of serum levels of gonadotropins, prolactin, androgens, estrogens, and progestins with physical changes.

Authors:  P A Lee; T Xenakis; J Winer; S Matsenbaugh
Journal:  J Clin Endocrinol Metab       Date:  1976-10       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.